Literature DB >> 21841768

Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.

Devon S Chabot-Richards1, David R Martin, Orrin B Myers, David R Czuchlewski, Kristin E Hunt.   

Abstract

Proliferation rates in diffuse large B-cell lymphoma have been associated with conflicting outcomes in the literature, more often with high proliferation associated with poor prognosis. In most studies, the proliferation rate was estimated by a pathologist using an immunohistochemical stain for the monoclonal antibody Ki-67. We hypothesized that a quantitative image analysis algorithm would give a more accurate estimate of the proliferation rate, leading to better associations with survival. In all, 84 cases of diffuse large B-cell lymphoma were selected according to the World Health Organization criteria. Ki-67 percentage positivity estimated by the pathologist was recorded from the original report. The same slides were then scanned using an Aperio ImageScope, and Ki-67 percentage positivity was calculated using a computer-based quantitative immunohistochemistry nuclear algorithm. In addition, chart review was performed and survival time was recorded. The Ki-67 percentage estimated by the pathologist from the original report versus quantitative image analysis was significantly correlated (P<0.001), but pathologist Ki-67 percentages were significantly higher than quantitative image analysis (P=0.021). There was less agreement at lower Ki-67 percentages. Comparison of Ki-67 percentage positivity versus survival did not show significant association either with pathologist estimate or quantitative image analysis. However, although not significant, there was a trend of worse survival at higher proliferation rates detected by the pathologist but not by quantitative image analysis. Interestingly, our data suggest that the Ki-67 percentage positivity as assessed by the pathologist may be more closely associated with survival outcome than that identified by quantitative image analysis. This may indicate that pathologists are better at selecting appropriate areas of the slide. More cases are needed to assess whether this finding would be statistically significant. Due to the good correlation between pathologist estimate and quantitative image analysis, there is no substantial benefit to using quantitative image analysis at this point of time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841768      PMCID: PMC3623285          DOI: 10.1038/modpathol.2011.123

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  27 in total

1.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

2.  Automated quantification of nuclear immunohistochemical markers with different complexity.

Authors:  Carlos López; Marylène Lejeune; María Teresa Salvadó; Patricia Escrivà; Ramón Bosch; Lluis E Pons; Tomás Alvaro; Jordi Roig; Xavier Cugat; Jordi Baucells; Joaquín Jaén
Journal:  Histochem Cell Biol       Date:  2008-01-03       Impact factor: 4.304

3.  Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

Authors:  S M Ansell; M Stenson; T M Habermann; D F Jelinek; T E Witzig
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

4.  Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.

Authors:  T P Miller; T M Grogan; S Dahlberg; C M Spier; R M Braziel; P M Banks; K Foucar; C R Kjeldsberg; N Levy; B N Nathwani
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

5.  Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

Authors:  Stefano Monti; Kerry J Savage; Jeffery L Kutok; Friedrich Feuerhake; Paul Kurtin; Martin Mihm; Bingyan Wu; Laura Pasqualucci; Donna Neuberg; Ricardo C T Aguiar; Paola Dal Cin; Christine Ladd; Geraldine S Pinkus; Gilles Salles; Nancy Lee Harris; Riccardo Dalla-Favera; Thomas M Habermann; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2004-11-18       Impact factor: 22.113

6.  Cell proliferation as a long-term prognostic factor in diffuse large-cell lymphomas.

Authors:  R Silvestrini; A Costa; P Boracchi; R Giardini; F Rilke
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

7.  Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.

Authors:  Adi Broyde; Olga Boycov; Yulia Strenov; Elimelech Okon; Ofer Shpilberg; Osnat Bairey
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

8.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

9.  Building an outcome predictor model for diffuse large B-cell lymphoma.

Authors:  Ana-Isabel Sáez; Antonio-José Sáez; María-Jesús Artiga; Alberto Pérez-Rosado; Francisca-Inmaculada Camacho; Ana Díez; Juan-Fernando García; Máximo Fraga; Ramón Bosch; Silvia-María Rodríguez-Pinilla; Manuela Mollejo; Cristina Romero; Lydia Sánchez-Verde; Marina Pollán; Miguel A Piris
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.

Authors:  Elton Rexhepaj; Donal J Brennan; Peter Holloway; Elaine W Kay; Amanda H McCann; Goran Landberg; Michael J Duffy; Karin Jirstrom; William M Gallagher
Journal:  Breast Cancer Res       Date:  2008-10-23       Impact factor: 6.466

View more
  7 in total

Review 1.  Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.

Authors:  R Andrew Harkins; Andres Chang; Sharvil P Patel; Michelle J Lee; Jordan S Goldstein; Selin Merdan; Christopher R Flowers; Jean L Koff
Journal:  Expert Rev Hematol       Date:  2019-09-12       Impact factor: 2.929

2.  Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.

Authors:  Mark A Samols; Nathan E Smith; Jonathan M Gerber; Milena Vuica-Ross; Christopher D Gocke; Kathleen H Burns; Michael J Borowitz; Toby C Cornish; Amy S Duffield
Journal:  Am J Clin Pathol       Date:  2013-10       Impact factor: 2.493

Review 3.  From drug discovery to biomarker-driven clinical trials in lymphoma.

Authors:  Anas Younes; Donald A Berry
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

4.  Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.

Authors:  Yizheng Wu; Ziang Xie; Junxin Chen; Jiaxin Chen; Weiyu Ni; Yan Ma; Kangmao Huang; Gangliang Wang; Jiying Wang; Jianjun Ma; Shuying Shen; Shunwu Fan
Journal:  Mol Cancer       Date:  2019-04-02       Impact factor: 27.401

5.  Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study.

Authors:  Fabian Huber; Elisabeth Zwickl-Traxler; Martin Pecherstorfer; Josef Singer
Journal:  Curr Oncol       Date:  2021-11-08       Impact factor: 3.677

6.  Quantitative histopathological assessment of ocular surface squamous neoplasia using digital image analysis.

Authors:  Rimvydas Ašoklis; Aistė Kadziauskienė; Rasa Paulavičienė; Donatas Petroška; Arvydas Laurinavičius
Journal:  Oncol Lett       Date:  2014-07-22       Impact factor: 2.967

7.  Persistent homology index as a robust quantitative measure of immunohistochemical scoring.

Authors:  Akihiro Takiyama; Takashi Teramoto; Hiroaki Suzuki; Katsushige Yamashiro; Shinya Tanaka
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.